Lupron Depot

Prostate Cancer

Lupron Depot is used to manage the symptoms of advanced prostate cancer. While it is not a cure, it helps slow the growth of cancer cells by reducing the amount of testosterone the body produces.

Endometriosis

This medication is prescribed to treat the pain associated with endometriosis, a condition where tissue similar to the lining of the uterus grows in other parts of the body. It may also be used to thin the uterine lining before certain surgical procedures.

Uterine Fibroids

Lupron Depot is used in combination with iron supplements to treat anemia caused by heavy menstrual bleeding from uterine fibroids. It is typically used for a short period to improve a patient's condition before surgery to remove the fibroids.

Central Precocious Puberty

In children, Lupron Depot is used to treat central precocious puberty (CPP). This condition causes a child's body to begin the process of changing into an adult body too soon. The medication helps delay the development of secondary sexual characteristics and slows the rate of bone maturation.

Hormone Suppression

Lupron Depot belongs to a class of medications known as gonadotropin-releasing hormone (GnRH) agonists. It works by acting on the pituitary gland, which is the part of the brain that signals the body to produce sex hormones. When the medication is first administered, it causes a brief increase in these hormones. However, with continuous use, the pituitary gland stops sending these signals, leading to a major decrease in hormone levels.

How It Affects Specific Conditions

• Prostate Cancer: Most prostate cancer cells rely on testosterone to grow. By lowering testosterone to very low levels, the medication can help slow or stop the progression of the cancer.
• Endometriosis and Uterine Fibroids: These conditions are often fueled by estrogen. Reducing estrogen levels can help shrink fibroid tissue and alleviate the pain and heavy bleeding associated with endometriosis.
• Central Precocious Puberty: In children who begin puberty too early, the medication suppresses the hormones that trigger physical changes, helping to delay puberty until a more appropriate age.

Because the medication initially stimulates hormone production before shutting it down, some patients may experience a temporary increase in symptoms, often called a flare, during the first few weeks of treatment.

Common Side Effects

Many people using Lupron Depot experience mild side effects. These may include:

• Hot flashes and increased sweating
• Pain, swelling, or redness at the injection site
• Headache or general body aches
• Nausea or stomach upset
• Changes in weight or appetite
• Decreased interest in sexual activity
• Mood swings or feeling tired
• Breast tenderness or swelling

Serious Side Effects

While less common, some side effects can be serious. Contact a healthcare provider immediately if you experience:

• Signs of an allergic reaction, such as rash, hives, or swelling of the face and throat
• Difficulty breathing or chest pain
• Fast or irregular heartbeat
• Severe bone or joint pain
• Difficulty urinating or blood in the urine
• Sudden numbness or weakness, particularly in the legs
• Vision changes or severe headache
• Seizures
• Increased thirst or frequent urination

In children being treated for early puberty, new or worsening vaginal bleeding or discharge may occur during the first few weeks of treatment.

Initial Symptom Flare

During the first few weeks of treatment, Lupron Depot causes a temporary increase in certain hormones. This can lead to a short-term worsening of symptoms, such as increased bone pain or difficulty urinating. In rare cases, this flare can cause serious issues like spinal cord compression or urinary tract blockage.

Pregnancy and Fertility

Lupron Depot must not be used during pregnancy as it can cause harm to a developing fetus or lead to pregnancy loss. Effective non-hormonal birth control should be used during treatment. This medication may also affect future fertility in both men and women.

Cardiovascular and Metabolic Risks

• Heart Health: There is an increased risk of heart attack, stroke, and sudden cardiac death. It may also affect the heart's electrical rhythm (QT prolongation).
• Diabetes: This medication may increase blood sugar levels and increase the risk of developing diabetes. Regular monitoring of blood glucose is often necessary.

Bone Density Loss

Long-term use of Lupron Depot can lead to thinning of the bones (osteoporosis). This may increase the risk of bone fractures. Healthcare providers may monitor bone mineral density during extended treatment.

Mental Health and Neurological Concerns

• Mood Changes: Patients may experience new or worsening depression, mood swings, or irritability.
• Seizures: Seizures have been reported in patients receiving this medication, including those without a prior history of seizure disorders.
• Pituitary Apoplexy: A rare but serious condition involving the pituitary gland can occur, typically within two weeks of the first injection. Symptoms include sudden headache, vomiting, and vision changes.

Pregnancy

Lupron Depot can cause serious harm to a developing fetus and should not be used during pregnancy. Before starting this medication, a pregnancy test is usually performed to confirm that a patient is not pregnant. If a person becomes pregnant while receiving treatment, they should notify their healthcare provider immediately.

Because Lupron Depot affects the hormonal system, individuals of childbearing age should use reliable, non-hormonal forms of birth control—such as condoms, a diaphragm, or a spermicide—during treatment and for some time after the final injection. Hormonal birth control methods may not be effective while using this drug.

Breastfeeding

It is not known if Lupron Depot passes into breast milk or how it might affect a nursing infant. Due to the potential for serious adverse reactions, healthcare providers typically advise against breastfeeding while using this medication. Patients should consult with their doctor to weigh the risks and benefits of treatment versus nursing.

Available Forms

Lupron Depot is available as an intramuscular injection. It is supplied in a kit containing a prefilled dual-chamber syringe with the medication in powder form and a liquid diluent for mixing before administration.

Dosing Strengths and Intervals

The medication is formulated for different release durations, which determine how frequently it is administered. These include:

• 1-month formulation: Administered once every 4 weeks.
• 3-month formulation: Administered once every 12 weeks.
• 4-month formulation: Administered once every 16 weeks.
• 6-month formulation: Administered once every 24 weeks.

The specific strength and frequency of the injection depend on the condition being treated, such as advanced prostate cancer, endometriosis, or uterine fibroids.

FDA-Approved Indications

Lupron Depot is approved by the U.S. Food and Drug Administration (FDA) for several specific medical conditions:

• Advanced Prostate Cancer: Used for the palliative treatment of advanced prostatic cancer.
• Endometriosis: Approved for the management of endometriosis, including pain relief and reduction of lesions.
• Uterine Fibroids: Used alongside iron therapy for the preoperative improvement of anemia caused by heavy vaginal bleeding from uterine fibroids.
• Central Precocious Puberty (CPP): Approved for the treatment of children with early-onset puberty.

Safety Communications and Monitoring

The FDA monitors the safety of Lupron Depot through various reporting systems. In 2017, the FDA identified a potential signal of serious risk regarding convulsions (seizures) associated with the use of gonadotropin-releasing hormone (GnRH) agonists, a class of drugs that includes leuprolide. The FDA evaluated this information to determine the need for regulatory action, such as updating the product labeling.

Regulatory Considerations

Lupron Depot is available only by prescription and is typically administered by a healthcare professional in a clinical setting. While it does not require a Risk Evaluation and Mitigation Strategy (REMS) program, the FDA-approved labeling includes warnings about the potential for a temporary increase in testosterone or estrogen levels during the first weeks of treatment, which may cause a brief worsening of symptoms.

Hormonal Changes After Stopping

Lupron Depot is a long-acting medication designed to release leuprolide slowly over one to six months. Because it remains in the system for an extended period, its effects do not stop immediately after the last injection. As the medication is gradually cleared from the body, testosterone or estrogen levels will begin to rise back toward their baseline.

Return of Symptoms

When hormone levels increase, the symptoms that Lupron Depot was managing may return. This can include:

• Return of pelvic pain or heavy bleeding in women treated for endometriosis or uterine fibroids.
• Resumption of the puberty process in children treated for central precocious puberty.
• Potential progression of prostate cancer in men as testosterone levels rise.

Recovery Timeline

The time it takes for the body to return to its pre-treatment state varies depending on the specific formulation used and the duration of treatment. For many women, menstruation typically resumes within two to three months after the medication from the last injection has worn off. In men, testosterone recovery can take several months, and in some instances, levels may not fully return to baseline if the medication was used for a long period.

Side effects experienced during treatment, such as hot flashes, mood changes, or bone density loss, may persist for some time after the final dose as the body adjusts to changing hormone levels.